| Patterned ballistic movements triggered by a startle in healthy humans J Valls‐Solé, JC Rothwell, F Goulart, G Cossu, E Muñoz The Journal of physiology 516 (3), 931-938, 1999 | 427 | 1999 |
| Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease M Quadri, A Federico, T Zhao, GJ Breedveld, C Battisti, C Delnooz, ... The American Journal of Human Genetics 90 (3), 467-477, 2012 | 409 | 2012 |
| The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life A Antonini, P Barone, R Marconi, L Morgante, S Zappulla, FE Pontieri, ... Journal of neurology 259, 2621-2631, 2012 | 265 | 2012 |
| Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study R Ceravolo, G Cossu, M Bandettini di Poggio, L Santoro, P Barone, ... Movement disorders 28 (10), 1391-1397, 2013 | 159 | 2013 |
| Defective temporal processing of sensory stimuli in DYT1 mutation carriers: a new endophenotype of dystonia? M Fiorio, M Gambarin, EM Valente, P Liberini, M Loi, G Cossu, G Moretto, ... Brain 130 (1), 134-142, 2007 | 154 | 2007 |
| Gut microbiota and metabolome alterations associated with Parkinson’s disease S Vascellari, V Palmas, M Melis, S Pisanu, R Cusano, P Uva, D Perra, ... Msystems 5 (5), 10.1128/msystems. 00561-20, 2020 | 152 | 2020 |
| Validation of the Italian version of the movement disorder society—unified Parkinson’s disease rating scale A Antonini, G Abbruzzese, L Ferini-Strambi, B Tilley, J Huang, ... Neurological Sciences 34, 683-687, 2013 | 138 | 2013 |
| A pilot trial of deferiprone for neurodegeneration with brain iron accumulation G Abbruzzese, G Cossu, M Balocco, R Marchese, D Murgia, M Melis, ... Haematologica 96 (11), 1708, 2011 | 133 | 2011 |
| LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study M Quadri, W Mandemakers, MM Grochowska, R Masius, H Geut, ... The Lancet Neurology 17 (7), 597-608, 2018 | 122 | 2018 |
| Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA … G Cossu, G Abbruzzese, G Matta, D Murgia, M Melis, V Ricchi, ... Parkinsonism & related disorders 20 (6), 651-654, 2014 | 110 | 2014 |
| Prepulse modulation of the startle reaction and the blink reflex in normal human subjects J Valls-Solé, F Valldeoriola, JL Molinuevo, G Cossu, F Nobbe Experimental Brain Research 129, 49-56, 1999 | 105 | 1999 |
| GBA‐Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort S Petrucci, M Ginevrino, I Trezzi, E Monfrini, L Ricciardi, A Albanese, ... Movement Disorders 35 (11), 2106-2111, 2020 | 95 | 2020 |
| Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease G Mulas, E Espa, S Fenu, S Spiga, G Cossu, E Pillai, E Carboni, ... Experimental neurology 286, 83-92, 2016 | 95 | 2016 |
| Broadening the phenotype of TARDBP mutations: the TARDBP Ala382Thr mutation and Parkinson’s disease in Sardinia M Quadri, G Cossu, V Saddi, EJ Simons, D Murgia, M Melis, A Ticca, ... Neurogenetics 12, 203-209, 2011 | 94 | 2011 |
| Restless legs syndrome in multiple sclerosis: A case‐control study M Deriu, G Cossu, A Molari, D Murgia, A Mereu, P Ferrigno, D Manca, ... Movement disorders: official journal of the Movement Disorder Society 24 (5 …, 2009 | 94 | 2009 |
| A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non‐demented Parkinson's disease patients P Barone, G Santangelo, L Morgante, M Onofrj, G Meco, G Abbruzzese, ... European journal of neurology 22 (8), 1184-1191, 2015 | 91 | 2015 |
| Pisa syndrome in Parkinson disease: an observational multicenter Italian study M Tinazzi, A Fasano, C Geroin, F Morgante, R Ceravolo, S Rossi, ... Neurology 85 (20), 1769-1779, 2015 | 90 | 2015 |
| Parkinson’s disease protein DJ-1 regulates ATP synthase protein components to increase neuronal process outgrowth R Chen, HA Park, N Mnatsakanyan, Y Niu, P Licznerski, J Wu, P Miranda, ... Cell death & disease 10 (6), 469, 2019 | 88 | 2019 |
| Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy D Manca, G Cossu, D Murgia, A Molari, P Ferrigno, E Marcia, M Melis Movement disorders: official journal of the Movement Disorder Society 24 (15 …, 2009 | 81 | 2009 |
| Effects of physical rehabilitation integrated with rhythmic auditory stimulation on spatio-temporal and kinematic parameters of gait in Parkinson’s disease M Pau, F Corona, R Pili, C Casula, F Sors, T Agostini, G Cossu, ... Frontiers in neurology 7, 195839, 2016 | 75 | 2016 |
Francesca MorganteSt George's University of LondonEmail verificata su sgul.ac.uk
